Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucosamine hydrochloride 1.5g tablets
1001050A0AAAHAH
|
Glucosamine hydrochloride | Glucosamine hydrochloride (Rheumatic) | Musculoskeletal and Joint Diseases | 1 |
|
Glucosamine sulfate 1.5g oral powder sachets sugar free
1001050B0AAAAAA
|
Glucosamine sulfate | Glucosamine sulfate (Rheumatic) | Musculoskeletal and Joint Diseases | 1 |
|
Guaifenesin 600mg modified-release tablets
1002020L0AAACAC
|
Guaifenesin (Systemic) | Guaifenesin | Musculoskeletal and Joint Diseases | 1 |
|
Humira 20mg/0.2ml solution for injection pre-filled syringes
1001030S0BBAFAF
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | 1 |
|
Hyaluronidase 1,500unit inj ampoules
1003010P0AAAAAA
|
Hyaluronidase | Hyaluronidase | Musculoskeletal and Joint Diseases | 1 |
|
Hydroxychloroquine 50mg/5ml oral liquid
1001030C0AAARAR
|
Hydroxychloroquine sulfate | Hydroxychloroquine sulfate | Musculoskeletal and Joint Diseases | 1 |
|
Hyrimoz 40mg/0.8ml solution for injection pre-filled pens
1001030S0BEAAAB
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | 1 |
|
Ibucalm 400mg tablets
1001010J0DHABAE
|
Ibucalm | Ibuprofen | Musculoskeletal and Joint Diseases | 1 |
|
Imraldi 40mg/0.8ml solution for injection pre-filled pens
1001030S0BFAAAB
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | 1 |
|
Indometacin 10mg/5ml oral liquid
1001010K0AAAXAX
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Indometacin 75mg modified-release tablets
1001010K0AAAJAJ
|
Indometacin (Systemic) | Indometacin | Musculoskeletal and Joint Diseases | 1 |
|
Kaolin poultices
1003020L0AAAAAA
|
Kaolin heavy | Kaolin heavy | Musculoskeletal and Joint Diseases | 1 |
|
Ketoprofen 100mg suppositories
1001010L0AAAPAP
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 1 |
|
Leflunomide 100mg tablets
1001030L0AAACAC
|
Leflunomide | Leflunomide | Musculoskeletal and Joint Diseases | 1 |
|
Metoject 10mg/0.2ml inj pre-filled syringes
1001030U0BEAGBF
|
Metoject (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 1 |
|
Myocrisin 10mg/0.5ml solution for injection ampoules
1001030J0BBACAC
|
Myocrisin | Sodium aurothiomalate | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen Cold and Flu tablets
1001010J0B4APBJ
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen Express 256mg caplets
1001010APBBACAA
|
Nurofen express (Ibuprofen sodium dihydrate) | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen Express 684mg caplets
1001010ADBEABAC
|
Nurofen Express (Ibuprofen Lysine) | Ibuprofen lysine | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen for Children Singles 100mg/5ml susp 5ml sach orange
1001010J0B4ALBM
|
Nurofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 1 |
|
Nurofen Pain Relief 256mg tablets
1001010APBCAAAA
|
Nurofen (Ibuprofen sodium dihydrate) | Ibuprofen sodium dihydrate | Musculoskeletal and Joint Diseases | 1 |
|
Pernaton Warming gel
100302000BBBXA0
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | 1 |
|
Pyridostigmine bromide 30mg/5ml oral solution
1002010Q0AAANAN
|
Pyridostigmine bromide | Pyridostigmine bromide | Musculoskeletal and Joint Diseases | 1 |
|
Pyridostigmine bromide 5mg/5ml oral solution
1002010Q0AAAYAY
|
Pyridostigmine bromide | Pyridostigmine bromide | Musculoskeletal and Joint Diseases | 1 |
|
Sarilumab 150mg/1.14ml inj pre-filled disposable devices
1001030ADAAACAC
|
Sarilumab | Sarilumab | Musculoskeletal and Joint Diseases | 1 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.